首页> 美国卫生研究院文献>other >Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

【2h】

Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

机译：在接受经皮冠状动脉介入治疗的患者中术前使用口服P2Y12抑制剂的相关趋势和结果：密歇根州心血管协会（BMC2）的蓝十字蓝盾的见解

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesWe sought to describe trends in the use of pre-procedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI).

机译：目的我们试图描述术前P2Y12抑制剂的使用趋势及其对经皮冠状动脉介入治疗（PCI）患者的临床影响。

著录项

期刊名称 other
作者
Devraj Sukul; Milan Seth; Simon R. Dixon; Akshay Khandelwal; Thomas A. LaLonde; Hitinder S. Gurm;
展开▼
作者单位

展开▼
年(卷),期 -1(29),10
年度 -1
页码 340–351
总页数 20
原文格式 PDF
正文语种
中图分类
关键词
P2Y12 inhibitor pretreatment percutaneous coronary intervention cardiovascular outcomes;

机译：P2Y12抑制剂;预处理;经皮冠状动脉介入治疗;心血管结果;

相似文献

外文文献

1. The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: Insights from the blue cross blue shield of michigan cardiovascular consortium (BMC2) [J] . KhambattaS., SethM., RosmanH.S., The American heart journal . 2013,第6期

机译：种族，治疗与接受当代经皮冠状动脉介入治疗的患者预后之间的关联：来自密歇根州心血管联盟（BMC2）的蓝色十字蓝盾的见解
2. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). [J] . Jackson EA, Moscucci M, Smith DE, The American heart journal . 2011,第1期

机译：在当代，原发性经皮冠状动脉介入治疗ST抬高型心肌梗死的患者中，性别与预后的关系：密歇根州心血管协会（BMC2）的Blue Cross Blue Shield的见解。
3. TCT-449 Trends in Utilization and Hospital Variation in the use of Mechanical Circulatory Support Devices in Patients Undergoing Percutaneous Coronary Intervention in Michigan: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) [J] . Thomas Earl, Milan Seth, Devraj Sukul, Journal of the American College of Cardiology . 2018,第13期

机译：TCT-449在密歇根患者中使用机械循环支持装置的利用和医院变化的趋势：密歇根心血管联盟蓝色横向蓝盾的见解（BMC2）
4. The Epidemiology and Outcomes of Percutaneous Coronary Intervention Before High‐Risk Noncardiac Surgery in Contemporary Practice: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry [O] . Palaniappan Muthappan, Dean Smith, Herbert D. Aronow, 2014

机译：高风险非心脏手术前经皮冠状动脉介入治疗的流行病学和结果在当代实践中：密歇根州心血管联合会（BMC2）注册局的蓝十字蓝盾的见解
5. The Epidemiology and Outcomes of Percutaneous Coronary Intervention Before High‐Risk Noncardiac Surgery in Contemporary Practice: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry [O] . Muthappan, Palaniappan, Smith, Dean, Aronow, Herbert D., 2014

机译：当代实践中高风险非心脏手术前经皮冠状动脉介入治疗的流行病学和结果：密歇根心血管联盟（BmC2）注册蓝洞蓝盾的见解

Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

摘要

著录项

相似文献

相关主题

期刊订阅